Clinical Trial Update: A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and pharmacokinetics of intravenous cefiderocol in combination with xeruborbactam in participants with renal impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections

Drugs mentioned

• Cefiderocol (cefiderocol)
• Xeruborbactam (xeruborbactam)

Snippet

Sponsor: Qpex Biopharma, Inc. | Conditions: Bacterial Infections | Phase 1 | Status: RECRUITING